Coherus Oncology, Inc. (CHRS)

1.00 +0.04 (+4.31%) USD  |  NASDAQ  |  Oct 20, 16:00
1.005 0.00 (0.00%) After-Hours: 20:00
More

Coherus Oncology Gross Profit (TTM) : 31.51M for June 30, 2026

Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 31.51M
March 31, 2026 28.15M
December 31, 2025 24.43M
September 30, 2025 20.58M
June 30, 2025 15.47M
March 31, 2025 16.92M
December 31, 2024 12.39M
September 30, 2024 14.33M
June 30, 2024 52.78M
March 31, 2024 78.47M
December 31, 2023 93.72M
September 30, 2023 117.93M
June 30, 2023 87.89M
March 31, 2023 103.78M
December 31, 2022 139.91M
September 30, 2022 170.24M
June 30, 2022 220.37M
March 31, 2022 241.55M
December 31, 2021 265.48M
September 30, 2021 302.95M
June 30, 2021 346.48M
March 31, 2021 401.27M
December 31, 2020 435.31M
September 30, 2020 452.40M
June 30, 2020 452.99M
Date Value
March 31, 2020 410.65M
December 31, 2019 336.80M
September 30, 2019 221.19M
June 30, 2019 115.96M
March 31, 2019 32.56M
December 31, 2018 -3.237M
September 30, 2018 -3.55M
June 30, 2018 -3.55M
March 31, 2018 -2.648M
December 31, 2017 -1.726M
September 30, 2017 -0.80M
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Enanta Pharmaceuticals, Inc. 60.35M
ACADIA Pharmaceuticals, Inc. 1.038B
Alnylam Pharmaceuticals, Inc. 3.827B
Anika Therapeutics, Inc. 75.00M
Savara, Inc. -0.281M